Clonal stability in children with acute lymphoblastic leukemia (ALL) who relapsed five or more years after diagnosis

Leukemia

Volumn 13, Issue 2, 1999, Pages 190-195

  Lo Nigro, L ^a   Cazzaniga, G ^b   Di Cataldo, A ^a   Pannunzio, A ^c   D'Aniello, E ^b   Masera, G ^b   Schiliro G ^a   Biondi, A ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c POLICLINICO   (Italy)

Author keywords

Childhood ALL; Clonality; Late relapse

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RECURRENCE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; T LYMPHOCYTE RECEPTOR GENE;

EID: 0033001725     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401269     Document Type: Article

References (23)

1. Pui CH. Childhood leukemias. New Engl J Med 1995; 332: 1618-1630.
2. Henze G, Fengler R, Hartmann R, Kornhuber B, Janka-Schaub G, Niethammer D, Riehm H. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood 1991; 78: 1166-1172.
3. Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G for the 'Associazione Italiana Ematologia Oncologia Pediatrica' (AIEOP). Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Haematologica 1998; 83: 791-799.
4. Ochs J, Mulhern RK. Late effects of antileukemic treatment. Pediatr Clin North Am 1988; 35: 815-833.
5. Beishuizen A, Verhoeven MA, Hahlen K, van Wering ER, van Dongen JJ. Differences in immunoglobulin heavy chain gene rearrangement patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis. Leukemia 1993; 7: 60-63.
6. Breit TM, Wolvers-Tettero IL, Beishuizen A, Verhoeven MA, van Wering ER, van Dongen JJ. Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-delta gene rearrangements in acute lymphoblastic leukemia. Blood 1993; 82: 3063-3074.
7. Beishuizen A, Verhoeven MA, van Wering ER, Hahlen K, Hooijkaas H, van Dongen JJ. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis. Blood 1994; 83: 2238-2247.
8. Marshall GM, Kwan E, Haber M, Brisco MJ, Sykes PJ, Morley AA, Toogood I, Waters K, Tauro G, Ekert H, Norris MD. Characterization of clonal immunoglobulin heavy chain and 1 cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia. Leukemia 1995; 9: 1847-1850.
9. Sterbergeen EJ, Verhagen OJHM, van Leeuwen EF, van der Berg H, von dem Borne AEGK, van der Schoot CE. Frequent ongoing T-cell receptor rearrangements in B-precursor acute lymphoblastic leukemia: implications for monitoring minimal residual disease. Blood 1995; 86: 692-702.
10. Steward CG, Goulden NJ, Katz F, Baines D, Martin PG, Langlands K, Potter MN, Chessels JM, Oakhill A. A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor d rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia. Blood 1994; 83: 1355-1362.
11. Davi F, Gocke C, Smith S, Sklar J. Lymphocytic progenitor cell origin and clonal evolution of human B-lineage acute lymphoblastic leukemia. Blood 1996; 88: 609-621.
12. Taylor JJ, Rowe D, Kylefjord H, Chessells J, Katz F, Proctor SJ, Middleton PG. Characterisation of non-concordance in the T-cell receptor gamma chain genes at presentation and clinical relapse in acute lymphoblastic leukemia. Leukemia 1994; 8: 60-66.
13. Levasseur M, Maung ZT, Jackson GH, Kernahan J, Proctor SJ, Middleton PG. Relapse of acute lymphoblastic leukaemia 14 years after presentation: use of molecular techniques to confirm true reemergence. Br J Haematol 1994; 87: 437-438.
14. Wassermann R, Yamada M, Ito Y, Finger LR, Reichard BA, Shane S, Lange B, Rovera G. VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia. Blood 1992; 79: 223-228.
15. Frost L, Goodeve A, Wilson G, Peake I, Barker H, Vora A. Clonal stability in late-relapsing childhood lymphoblastic leukaemia. Br J Haematol 1997; 98: 992-994.
16. Ghali DW, Panzer S, Fischer S, Argyriou-Tirita A, Haas OA, Kovar H, Gadner H, Panzer-Grumayer ER. Heterogeneity of the T-cell receptor delta gene indicating subclone formation in acute precursor B-cell leukemias. Blood 1995; 85: 2795-2801.
17. van der Does-van den Berg A, Bartram C, Basso G, Benoit YCM, Biondi A, Debatin KM, Haas OA, Harbott J, Kamps WA, Koller U, Lampert F, Kudwig WD, Niemeyer CM, van Wering E. Minimal requirements for the diagnosis, classification and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the 'BFM Family' Cooperative Group. Med Ped Oncol 1992; 20: 497-505.
18. Bottaro M, Berti E, Biondi A, Migone N, Crosti L. Heteroduplex analysis of T-cell receptor γ gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas. Blood 1994; 83: 3271-3278.
19. Lefranc MP, Forster A, Rabbitts TH. Rearrangement of two distinct T-cell gamma-chain variable-region genes in human DNA. Nature 1986; 319: 420-422.
20. Pongers-Willemse MJ, Seriu T, Stolz F, d'Aniello E, Gameiro P, Pisa P, Gonzales M, Bartram CR, Panzer-Grumayer ER, Biondi A, San Miguel JF, van Dongen JJM. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using Immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Leukemia 1999; 13: 110-118.
21. Vora A, Frost L, Goodeve A, Wilson G, Ireland RM, Lilleyman J, Eden T, Peake I, Richards S. Late relapsing childhood lymphoblastic leukemia. Blood 1998; 92: 2334-2337.
22. Roberts WM, Estrov Z, Ouspenskaia MV, Johnston DA, McClain KL, Zipf TF. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. New Engl J Med 1997; 336: 317-323.
23. van Dongen JJM, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig WD, Basso G, de Brujin MAC, Cazzaniga G, Hettinger K, van der Does-van der Berg A, Hop WCJ, Riehm H, Bartram CR. Prognostic value of minimal residual disease in childhood acute lymphoblastic leukemia: a prospective study of the International BFM study group. Lancet 1998; 352: 1731-1738.